Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enrich Biosystems is a biotechnology company specializing in high-throughput, microfluidics-free cell discovery and isolation platforms. The company's flagship TROVO system utilizes dissolvable microwells and AI-powered imaging to enable the functional profiling and precise retrieval of live cells, addressing critical gaps in cell therapy development and single-cell analysis. By focusing on cell behavior and kinetics rather than just surface markers, Enrich Biosystems helps researchers identify the most potent therapeutic candidates, such as CAR-T and NK cells, with higher efficiency and preserved cell viability. The platform is designed to accelerate workflows in immuno-oncology, stem cell research, and precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enrich.